International Conference on Molecular Oncology and Oncogenesis
ICMOO
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the intricate molecular pathways that contribute to oncogenesis. Participants will explore the genetic and epigenetic alterations that drive tumorigenesis.
SDG 3
SDG 4
This session will examine the latest epidemiological data on cancer incidence and prevalence across diverse populations. Discussions will include risk factors and their implications for public health.
SDG 3
SDG 10
This track will highlight recent advancements in the identification and validation of cancer biomarkers. Emphasis will be placed on their role in early detection and personalized medicine.
SDG 3
SDG 9
This session will focus on effective strategies for cancer prevention, including lifestyle modifications and vaccination programs. Participants will discuss the impact of public health initiatives on reducing cancer risk.
SDG 3
SDG 4
This track will explore novel therapeutic targets in cancer treatment, including targeted therapies and immunotherapies. The session aims to discuss the mechanisms of action and clinical implications of these treatments.
SDG 3
SDG 9
This session will address the disparities in cancer care and outcomes among different demographic groups. Participants will analyze the social determinants of health that influence access to treatment.
SDG 3
SDG 10
This track will delve into the application of genomic and proteomic technologies in understanding cancer biology. The focus will be on how these approaches can inform therapeutic decisions.
SDG 3
SDG 9
This session will provide insights into the design and implementation of clinical trials in oncology. Discussions will include challenges and opportunities in translating research findings into clinical practice.
SDG 3
SDG 10
This track will explore the role of palliative care in enhancing the quality of life for cancer patients. Participants will discuss strategies for managing symptoms and providing holistic support.
SDG 3
SDG 4
This session will focus on the latest technological advancements in cancer diagnosis, including imaging and liquid biopsy techniques. The potential for these technologies to revolutionize early detection will be emphasized.
SDG 3
SDG 9
This track will examine global initiatives and policies aimed at cancer control and prevention. Participants will discuss collaborative efforts and the role of international organizations in addressing the cancer burden.
SDG 3
SDG 10